
Anema133 ml
Square Pharmaceuticals PLC.
Diabasic Sodium Phosphate + Monobasic Sodium Phosphate is an osmotic (saline) laxative combination indicated for: Established/approved use: Relief of occasional constipation (short-term use and more.
Diabasic Sodium Phosphate + Monobasic Sodium Phosphate is an osmotic (saline) laxative combination indicated for:
Diabasic Sodium Phosphate + Monobasic Sodium Phosphate is not intended for chronic or repeated use and should be used strictly according to the dose and frequency on the product label or as directed by a physician.
| Indication | Formulation | Typical Adult Dose |
|---|---|---|
| Occasional constipation | Oral solution | As directed on the product label, mixed with water; not to exceed the labeled maximum single or 24-hour dose. |
| Bowel cleansing before colonoscopy | Oral solution | Given in divided doses (evening before and/or morning of the procedure) as part of a physician-directed bowel-preparation protocol, together with additional clear fluids. |
| Occasional constipation | Rectal enema | One standard enema administered rectally as a single dose; do not repeat within 24 hours unless directed by a physician. |
Do not exceed the labeled dose or frequency of Diabasic Sodium Phosphate + Monobasic Sodium Phosphate. Repeated or excessive dosing has been associated with serious, sometimes fatal, electrolyte disturbances and kidney injury (see Precautions and Warnings).
Use in children should only be under direct medical supervision; oral bowel-preparation dosing (if used) should follow weight-based, physician-directed protocols. Rectal enema use should generally be avoided in young children per labeled age restrictions (see Use in Special Populations).
Diabasic Sodium Phosphate + Monobasic Sodium Phosphate should generally be avoided in patients with significant renal impairment; if any use is considered in mild renal impairment, it should only be under close physician supervision with monitoring (see Contraindications).
Common, generally mild side effects of Diabasic Sodium Phosphate + Monobasic Sodium Phosphate include:
Serious but less common effects: significant electrolyte disturbances (hyperphosphatemia, hypocalcemia, hypernatremia) and dehydration; rarely, acute phosphate nephropathy (a form of acute kidney injury) has been reported, particularly with excessive dosing or in at-risk patients (see Precautions and Warnings and Contraindications). Seek prompt medical attention for severe abdominal pain, reduced urination, unusual weakness, or signs of dehydration.
Diabasic Sodium Phosphate + Monobasic Sodium Phosphate is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.